Common Names: Chinese lobelia
Researchers explored the potential of flavonoids as COVID-19 treatment options. Through virtual screening, they identified amentoflavone, found in plants like Ginkgo biloba, as a potential multitarget inhibitor against essential non-structural proteins of the virus. Molecular docking calculations and structural analysis support this potential. Amentoflavone is widely available, low-cost, has no side effects, and a long history of use. Future experiments are needed to validate its effectiveness as an inhibitor against SARS-CoV-2.